Treatment with licochalcone A decreased the protein level of survivin, but not Bcl‐2, Bcl‐xL or Mcl‐1, robustly in either WT or mutant EGFR‐expressing NSCLC cells (Figure 4F). The gene discussed is EGFR; the disease is non-small cell lung carcinoma.